• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻型结外NK/T细胞淋巴瘤中JAK/STAT级联反应的基因改变与组蛋白修饰

Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.

作者信息

Lee Seungbok, Park Ha Young, Kang So Young, Kim Seok Jin, Hwang Jinha, Lee Seungho, Kwak Soo Heon, Park Kyong Soo, Yoo Hae Yong, Kim Won Seog, Kim Jong-Il, Ko Young Hyeh

机构信息

Genomic Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul, Korea.

Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.

出版信息

Oncotarget. 2015 Jul 10;6(19):17764-76. doi: 10.18632/oncotarget.3776.

DOI:10.18632/oncotarget.3776
PMID:25980440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4627344/
Abstract

Extranodal NK/T-cell lymphoma nasal type (ENKL) is a rare type of non-Hodgkin lymphoma that more frequently occurs in East Asia and Latin America. Even though its molecular background has been discussed in the last few years, the current knowledge does not explain the disease pathogenesis in most cases of ENKL. Here, we performed multiple types of next-generation sequencing on 34 ENKL samples, including whole-exome sequencing (9 cancer tissues and 4 cancer cell lines), targeted sequencing (21 cancer tissues), and RNA sequencing (3 cancer tissues and 4 cancer cell lines). Mutations were found most frequently in 3 genes, STAT3, BCOR, and MLL2 (which were present in 9, 7, and 6 cancer samples, respectively), whereas there were only 2 cases of JAK3 mutation. In total, JAK/STAT pathway- and histone modification-related genes accounted for 55.9% and 38.2% of cancer samples, respectively, and their involvement in ENKL pathogenesis was also supported by gene expression analysis. In addition, we provided 177 genes upregulated only in cancer tissues, which appear to be linked with angiocentric and angiodestructive growth of ENKL. In this study, we propose several novel driver genes of ENKL, and show that these genes and their functional groups may be future therapeutic targets of this disease.

摘要

鼻型结外NK/T细胞淋巴瘤(ENKL)是一种罕见的非霍奇金淋巴瘤,在东亚和拉丁美洲更为常见。尽管在过去几年中已经讨论了其分子背景,但目前的知识并不能解释大多数ENKL病例的疾病发病机制。在此,我们对34例ENKL样本进行了多种类型的二代测序,包括全外显子测序(9个癌组织和4个癌细胞系)、靶向测序(21个癌组织)和RNA测序(3个癌组织和4个癌细胞系)。在3个基因中最常发现突变,即STAT3、BCOR和MLL2(分别存在于9个、7个和6个癌症样本中),而JAK3突变仅有2例。总的来说,JAK/STAT通路相关基因和组蛋白修饰相关基因分别占癌症样本的55.9%和38.2%,基因表达分析也支持它们参与ENKL发病机制。此外,我们提供了177个仅在癌组织中上调的基因,这些基因似乎与ENKL的血管中心性和血管破坏性生长有关。在本研究中,我们提出了几个ENKL的新型驱动基因,并表明这些基因及其功能组可能是该疾病未来的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/1b2e0295bc3e/oncotarget-06-17764-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/da7667a63390/oncotarget-06-17764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/20597352da0a/oncotarget-06-17764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/0c122c720477/oncotarget-06-17764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/3fb32291fa07/oncotarget-06-17764-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/1b2e0295bc3e/oncotarget-06-17764-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/da7667a63390/oncotarget-06-17764-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/20597352da0a/oncotarget-06-17764-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/0c122c720477/oncotarget-06-17764-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/3fb32291fa07/oncotarget-06-17764-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da5/4627344/1b2e0295bc3e/oncotarget-06-17764-g005.jpg

相似文献

1
Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.鼻型结外NK/T细胞淋巴瘤中JAK/STAT级联反应的基因改变与组蛋白修饰
Oncotarget. 2015 Jul 10;6(19):17764-76. doi: 10.18632/oncotarget.3776.
2
Extranodal NK/T-cell lymphoma: Updates in biology and management strategies.结外NK/T细胞淋巴瘤:生物学及治疗策略的进展
Best Pract Res Clin Haematol. 2018 Sep;31(3):315-321. doi: 10.1016/j.beha.2018.07.002. Epub 2018 Jul 3.
3
Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.拉丁美洲鼻型结外NK/T细胞淋巴瘤的突变谱和EBV毒株
Mod Pathol. 2020 May;33(5):781-791. doi: 10.1038/s41379-019-0415-5. Epub 2019 Dec 10.
4
Frequent Mutations in Natural Killer/T Cell Lymphoma.自然杀伤/ T细胞淋巴瘤中的常见突变
Cell Physiol Biochem. 2018;49(1):1-16. doi: 10.1159/000492835. Epub 2018 Aug 22.
5
Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.鼻型结外NK/T细胞淋巴瘤中频繁出现的BCOR畸变。
Genes Chromosomes Cancer. 2016 May;55(5):460-71. doi: 10.1002/gcc.22348. Epub 2016 Feb 10.
6
Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.结外 NK/T 细胞淋巴瘤,鼻型中的新型 JAK3 激活突变。
Am J Pathol. 2017 May;187(5):980-986. doi: 10.1016/j.ajpath.2017.01.004. Epub 2017 Mar 9.
7
Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).JAK-STAT 通路相关基因与淋巴瘤风险的关联:一项欧洲病例对照研究(EpiLymph)的结果。
Br J Haematol. 2011 May;153(3):318-33. doi: 10.1111/j.1365-2141.2011.08632.x. Epub 2011 Mar 21.
8
Targeting the JAK/STAT pathway in cytotoxic T lymphocytes (CTL) by Next Generation Sequencing (NGS).通过下一代测序(NGS)靶向细胞毒性T淋巴细胞(CTL)中的JAK/STAT信号通路。
Methods Mol Biol. 2014;1186:253-68. doi: 10.1007/978-1-4939-1158-5_14.
9
Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.通过单细胞RNA测序分析建立表达神经节苷脂GD2的结外NK/T细胞淋巴瘤细胞系
Exp Hematol. 2024 Feb;130:104132. doi: 10.1016/j.exphem.2023.11.006. Epub 2023 Nov 27.
10
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.经典型霍奇金淋巴瘤中 JAK-STAT 通路基因的普遍突变。
Blood. 2018 May 31;131(22):2454-2465. doi: 10.1182/blood-2017-11-814913. Epub 2018 Apr 12.

引用本文的文献

1
Functional screening of somatic mutant events in extranodal natural killer/T-cell lymphoma with adrenal involvement.肾上腺受累的结外自然杀伤/T细胞淋巴瘤体细胞突变事件的功能筛选
Front Immunol. 2025 May 13;16:1566794. doi: 10.3389/fimmu.2025.1566794. eCollection 2025.
2
Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases.EZH2在鼻部疾病中的作用机制及治疗意义
Clin Rev Allergy Immunol. 2025 May 5;68(1):46. doi: 10.1007/s12016-025-09058-x.
3
BCOR abnormalities in endometrial stromal sarcoma.子宫内膜间质肉瘤中的BCOR异常

本文引用的文献

1
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.使用DESeq2对RNA测序数据的倍数变化和离散度进行适度估计。
Genome Biol. 2014;15(12):550. doi: 10.1186/s13059-014-0550-8.
2
HTSeq--a Python framework to work with high-throughput sequencing data.HTSeq——一个用于处理高通量测序数据的Python框架。
Bioinformatics. 2015 Jan 15;31(2):166-9. doi: 10.1093/bioinformatics/btu638. Epub 2014 Sep 25.
3
Comprehensive molecular characterization of gastric adenocarcinoma.胃腺癌的全面分子特征分析。
Gynecol Oncol Rep. 2025 Jan 7;57:101672. doi: 10.1016/j.gore.2024.101672. eCollection 2025 Feb.
4
Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices.与临床预后指标相关分析的结外NK/T细胞淋巴瘤的突变特征。
Ann Hematol. 2024 Dec;103(12):5749-5757. doi: 10.1007/s00277-024-06035-w. Epub 2024 Nov 26.
5
EBV-Related Lymphoproliferative Diseases: A Review in Light of New Classifications.EB病毒相关淋巴增殖性疾病:基于新分类的综述
Mediterr J Hematol Infect Dis. 2024 May 1;16(1):e2024042. doi: 10.4084/MJHID.2024.042. eCollection 2024.
6
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations.结外 NK/T 细胞淋巴瘤突变谱分析:临床与预后相关性研究。
Ann Hematol. 2024 Aug;103(8):2917-2930. doi: 10.1007/s00277-024-05698-9. Epub 2024 Apr 27.
7
A lineage-specific STAT5BN642H mouse model to study NK-cell leukemia.一种用于研究自然杀伤细胞白血病的谱系特异性STAT5B N642H小鼠模型。
Blood. 2024 Jun 13;143(24):2474-2489. doi: 10.1182/blood.2023022655.
8
Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?结外NK/T细胞淋巴瘤,鼻型:过去十年取得了哪些进展?
Front Oncol. 2023 Jul 17;13:1175545. doi: 10.3389/fonc.2023.1175545. eCollection 2023.
9
Histone methyltransferase KMT2D inhibits ENKTL carcinogenesis by epigenetically activating SGK1 and SOCS1.组蛋白甲基转移酶 KMT2D 通过表观遗传激活 SGK1 和 SOCS1 抑制 ENKTL 癌发生。
Genes Genomics. 2024 Feb;46(2):203-212. doi: 10.1007/s13258-023-01434-1. Epub 2023 Jul 31.
10
"Sandwich" protocol based on modified SMILE regimen for children with newly extranodal NK/T cell lymphoma, nasal type: a single-arm, single-center clinical study.基于改良 SMILE 方案的“三明治”方案治疗初治结外鼻型 NK/T 细胞淋巴瘤患儿:单臂、单中心临床研究。
Ann Hematol. 2023 Nov;102(11):3143-3152. doi: 10.1007/s00277-023-05375-3. Epub 2023 Jul 24.
Nature. 2014 Sep 11;513(7517):202-9. doi: 10.1038/nature13480. Epub 2014 Jul 23.
4
Epigenetic regulation of EBV persistence and oncogenesis.EBV持续存在和肿瘤发生的表观遗传调控。
Semin Cancer Biol. 2014 Jun;26:22-9. doi: 10.1016/j.semcancer.2014.01.003. Epub 2014 Jan 24.
5
Systematic evaluation of spliced alignment programs for RNA-seq data.系统评估 RNA-seq 数据拼接比对程序。
Nat Methods. 2013 Dec;10(12):1185-91. doi: 10.1038/nmeth.2722. Epub 2013 Nov 3.
6
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.BCOR 和 BCORL1 突变在骨髓增生异常综合征及相关疾病中的作用。
Blood. 2013 Oct 31;122(18):3169-77. doi: 10.1182/blood-2012-11-469619. Epub 2013 Sep 18.
7
Genetic loss of SH2B3 in acute lymphoblastic leukemia.急性淋巴细胞白血病中 SH2B3 的遗传缺失。
Blood. 2013 Oct 3;122(14):2425-32. doi: 10.1182/blood-2013-05-500850. Epub 2013 Aug 1.
8
Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan.日本自然杀伤细胞肿瘤中JAK3突变的罕见发生情况。
Leuk Lymphoma. 2014 Apr;55(4):962-3. doi: 10.3109/10428194.2013.819577. Epub 2013 Jul 29.
9
Mutational heterogeneity in cancer and the search for new cancer-associated genes.癌症中的突变异质性与新的癌症相关基因的寻找。
Nature. 2013 Jul 11;499(7457):214-218. doi: 10.1038/nature12213. Epub 2013 Jun 16.
10
Molecular underpinning of extranodal NK/T-cell lymphoma.结外 NK/T 细胞淋巴瘤的分子基础。
Best Pract Res Clin Haematol. 2013 Mar;26(1):57-74. doi: 10.1016/j.beha.2013.04.006. Epub 2013 May 23.